Generic and innovative drugs market in Central Europe 2013 by michalgilly


									Generic and innovative drugs market in Central Europe 2013

Compare generic & innovative drug markets across Central Europe.
 Report studies reimbursement regulations; forecasts market growth for 2013-2015.
 Generic and innovative medicines represent key advancements in the regional pharmaceutical industry of
Central Europe. The markets for these preparations have become especially complex due to varying conditions
that exist in each individual country. For example, generics represent a larger share of the market in Poland
than in Romania, Slovakia, the Czech Republic, Hungary or Bulgaria. In addition, innovative drug segments
have experienced different growth rates across borders, and regulatory and reimbursement policies vary from
country to country and are subject to change with the passage of each new legislative measure.
 Now there is a convenient way to stay updated on changes and understand developments in these
high-potential markets. Readers recommend Generic and innovative drugs market in Central Europe 2013,
Comparative analysis, reimbursement policies and development forecasts for 2013-2015.
 This comprehensive report from PMR includes statistics on value and volume of the overall regional CE
market and zeroes in on the specifics of the generic and innovative drug segments in each of six Central
European countries: Poland, Romania, Slovakia, the Czech Republic, Hungary and Bulgaria. It supplies
market share of each segment within the overall pharmaceutical sector of each country, along with detailed
forecasts for growth and expansion in 2013-2015.
 Readers will learn about drug pricing variations in each country, from VAT rates and allowable mark-ups to
government regulations governing drug prices in connection to reimbursement list status. The report examines
entire reimbursement systems in each country in terms of listing, modifications and procedures and policies in
each specific country, along with changes expected to occur in the years ahead. It also features coverage of
patent expiry periods and data exclusivity periods in each country, with lists of SPCs (Supplementary
Protection Certificates) currently issued in each of the six highlighted countries.
 This publication also provides detailed coverage of additional topics including the market shares of
counterfeit products in each country, the specific procedures used to deal with these products, attitudes of
patients and medical professionals toward the use of generic and innovative preparations and best selling
generic and innovative drugs in the CE market and in each country.
 Viewed by many users as seven reports in one, Generic and innovative drugs market in Central Europe 2013,
Comparative analysis, reimbursement policies and development forecasts for 2013-2015 is a powerful tool for
professionals who wish to perform comparative analysis of conditions in these important market segments as
they exist in each country within the region. It is also an affordable and worthwhile compendium of essential
guidance for those seeking updates on reimbursement lists and policies in these six countries, creating a new
business strategy or preparing a winning product portfolio.
 Manufacturers, distributors, trade groups, consultants, financial services specialists and academic and
research concerns represent just a few of the organisations occupied by professionals who will benefit from
access to this unique and timely business intelligence resource.

table Of Content

Generic and innovative drugs market in Central Europe 2013
i. Methodology 15
ii. Executive Summary 21
iii. Characteristics Of Generic And Innovative Drug Markets In Central European Countries 31
iv. Bestselling Drugs In Central Europe 93
v. Counterfeit Products 117
vi. Reimbursement And Pricing Policies In Central Europe 123
vii. Key Manufacturers 213
viii. List Of Graphs 289
ix. List Of Tables 295
x. About Pmr 301

ResearchMoz( is the one stop online destination to find and buy market research
reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our
huge collection of market research reports. We provide our services to all sizes of organizations and across all
industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as
publishers and will assist you in making an informed decision by giving you unbiased and deep insights on
which reports will satisfy your needs at the best price.

M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948

Generic and innovative drugs market in Central Europe 2013

To top